SNDX
Syndax Pharmaceuticals Inc
17.80$
+1.3%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +53.5% | -11.4% | -12.2% | -10.7% | +70.2% | -11.6% | -7.0% | -7.4% | -4.0% | -10.8% | +48.9% | |
| – | +52.5% | -21.9% | -1.7% | -7.0% | +45.4% | -9.0% | -3.1% | -0.3% | -0.3% | -10.8% | +43.3% | |
| – | +212.4% | -61.2% | -8.0% | +26.2% | +15.8% | -0.1% | -29.5% | +7.5% | +15.5% | -3.0% | +157.1% | |
| – | +58.9% | -24.8% | -2.2% | -8.3% | +49.6% | -11.4% | -9.2% | -3.1% | -13.2% | -10.7% | +55.6% | |
| – | -70.8% | +518.3% | +43.4% | -56.9% | +195.8% | +54.9% | +74.2% | +15.1% | -11.8% | +59.7% | +15.6% | |
| – | -25.3% | – | – | – | – | +1,174.3% | +279.4% | +41.3% | +31.0% | +6.7% | -5.1% | |
| – | +46.6% | -12.9% | -16.7% | +39.4% | +635.4% | -2.5% | +3.1% | -0.5% | +6.6% | -7.3% | +59.7% | |
| – | +48.3% | -12.5% | -16.4% | +39.8% | +74.4% | -8.7% | +19.5% | +1.1% | +5.2% | -28.3% | +15.7% | |
| – | +4.1% | +0.7% | -5.8% | -14.2% | +1,378.4% | -97.0% | -8.9% | +6,544.6% | -98.0% | +3.4% | +3.7% | |
| – | +184.2% | -48.8% | +31.3% | -57.7% | +137.4% | -13.6% | +72.7% | -20.3% | +19.9% | -34.6% | -55.0% | |
| – | – | – | – | – | – | – | – | – | – | +0.0% | +71.0% | |
| – | +54.3% | -11.2% | -11.7% | -15.6% | -21.4% | -25.4% | -26.8% | -26.7% | -44.0% | -35.6% | -63.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +3.8% | +17.5% | +0.1% | +0.2% | +0.4% | -0.2% | +0.8% | +0.3% | +0.0% | +0.0% | +2.7% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.